IRTC - iRhythm Technologies, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $-0.64
|
Rev Est: $194.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$210.91
DETAILS
HIGH:
$244.00
LOW:
$184.00
MEDIAN:
$210.00
CONSENSUS:
$210.91
UPSIDE:
53.84%
Market Cap:
4.42B
Volume:
663,152
Avg Volume:
567,315
52 Week Range:
92.52-212
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.07
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
2,000
IPO Date:
2016-10-20
EPS (TTM):
-1.39
P/E Ratio:
-127.47
Revenue (TTM):
747.14M
Total Assets:
1.02B
Total Debt:
731.18M
Cash & Equiv:
236.01M
Rev Growth (5Y):
23.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-4.2%
Debt/Equity:
4.79
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $0.29 | $0.02 | +1350.0% | $208.9M | $192.4M | +8.6% |
| 2025-10-30 | $-0.06 | $-0.36 | +83.3% | $192.9M | $201.8M | -4.4% |
| 2025-07-31 | $-0.32 | $-0.53 | +39.6% | $186.7M | $175.5M | +6.4% |
| 2025-05-01 | $-0.95 | $-0.89 | -6.7% | $158.7M | $153.4M | +3.4% |
| 2025-02-20 | $0.01 | $-0.29 | +103.4% | $164.3M | $158.3M | +3.8% |
| 2024-10-30 | $-1.26 | $-0.55 | -129.1% | $147.5M | $157.3M | -6.2% |
| 2024-08-01 | $-0.61 | $-0.92 | +33.7% | $148.0M | $146.2M | +1.3% |
| 2024-05-02 | $-1.47 | $-0.99 | -48.5% | $131.9M | $128.4M | +2.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 747.14M | 591.84M | 492.68M | 410.92M | 322.82M | 265.17M | 214.55M | 147.28M | 99.13M | 64.07M | 36.14M | 21.75M |
| Net Income | (44.55M) | (113.29M) | (123.41M) | (116.16M) | (101.36M) | (43.83M) | (54.57M) | (50.38M) | (29.74M) | (20.90M) | (22.80M) | (15.83M) |
| EPS | -1.39 | -3.63 | -4.04 | -3.88 | -3.46 | -1.58 | -2.16 | -2.02 | -1.30 | -3.95 | -1.54 | -1.07 |
| Total Assets | 1.02B | 931.45M | 433.14M | 448.22M | 462.97M | 511.74M | 306.21M | 119.71M | 133.12M | 138.16M | 37.87M | 18.51M |
| Total Debt | 731.18M | 736.91M | 129.82M | 131.04M | 117.71M | 122.47M | 128.59M | 34.90M | 33.98M | 32.23M | 30.55M | 6.25M |
| Cash & Equivalents | 236.01M | 419.60M | 36.17M | 78.83M | 127.56M | 88.63M | 20.46M | 20.02M | 8.67M | 51.64M | 25.21M | 8.62M |
| Operating Cash Flow | 80.86M | 3.39M | (50.10M) | (23.01M) | (37.75M) | (13.76M) | (21.86M) | (29.07M) | (14.91M) | (16.65M) | (18.00M) | (15.63M) |
| Free Cash Flow | 34.52M | (30.55M) | (90.53M) | (52.84M) | (65.82M) | (27.31M) | (42.32M) | (34.25M) | (18.47M) | (19.41M) | (19.79M) | (16.16M) |
| FCF per Share | 1.08 | -0.98 | -2.97 | -1.77 | -2.24 | -0.98 | -1.67 | -1.43 | -0.82 | -3.67 | -1.34 | -1.09 |
| Book Value | 152.75M | 90.91M | 210.10M | 239.81M | 279.51M | 341.61M | 135.41M | 54.42M | 79.55M | 92.56M | (101.62M) | 7.26M |
| Cash & ST Investments | 583.76M | 535.55M | 133.76M | 213.14M | 239.13M | 335.22M | 140.55M | 78.34M | 102.36M | 106.05M | 25.21M | 8.62M |
| ROC Equity | -0.29 | -1.25 | -0.59 | -0.48 | -0.36 | -0.13 | -0.40 | -0.93 | -0.37 | -0.23 | N/A | -2.18 |